Latest Breaking News On - Tempest therapeutics chart - Page 1 : comparemela.com

19.09.2023 - BRISBANE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) - Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, announced today . Seite 1

Calithera biosciencesTom dubenskyFred hutchinson cancer research centerResearch pathwayUniversity of washingtonVentirx pharmaceuticalsSeattle cancer care allianceClark collegeScientist training programSeattle cancer careFred hutchinson cancer researchMedical scientist training programTempest therapeutics chartEmpest therapeutics kursEmpest therapeutics aktie